Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

After adding nearly 30% in the previous session following its better-than-expected Q4 results for FY24, Embecta (NASDAQ:EMBC) ...

BTIG upgraded Embecta (EMBC) to Buy from Neutral with a $26 price target Shares gained about 30% in Tuesday trading as investors rewarded ...

BTIG analyst Gray Powell raised the firm’s price target on Zscaler (ZS) to $238 from $205 and keeps a Buy rating on the shares. The firm’s ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...

Oil (CL1:COM) prices and the broader energy sector have been among the worst-performing areas of the economy since the start ...

BTIG analyst Andrew Harte is praising MicroStrategy's (NASDAQ:MSTR) plan announced at the end of October to raise $42B of ...

On Tuesday, Vuzix Corp (VUZI) stock saw a decline, ending the day at $1.97 which represents a decrease of $-0.28 or -12.44% from the prior close of $2.25. The stock opened at $2.38 and touched a low ...

Alector (NASDAQ:ALEC – Free Report) had its target price lowered by BTIG Research from $16.00 to $5.00 in a research note ...

A former executive at StoneX Group Inc. admitted to stealing trade secrets from his prior employer BTIG LLC, a surprise twist ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable ...

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired full ex-China rights to an anti-TSLP humanized mAb and ...